4% paraformaldehyde fix solution (pfa) (Brickell Biotech)
90
Structured Review
Brickell Biotech
4% paraformaldehyde fix solution (pfa)
4% Paraformaldehyde Fix Solution (Pfa), supplied by Brickell Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraformaldehyde+fixative+solution/4++paraformaldehyde+fix+solution/pmc12048567-75-1-6
Average 90 stars, based on 1 article reviews
4% Paraformaldehyde Fix Solution (Pfa), supplied by Brickell Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paraformaldehyde+fixative+solution/4++paraformaldehyde+fix+solution/pmc12048567-75-1-6
Average 90 stars, based on 1 article reviews
4% paraformaldehyde fix solution (pfa) - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "A double-agent microRNA regulates viral cross-kingdom infection in animals and plants"
Article Title: A double-agent microRNA regulates viral cross-kingdom infection in animals and plants
Journal: The EMBO Journal
doi: 10.1038/s44318-025-00405-4
Figure Legend Snippet: Reagents and tools table
Techniques Used: Virus, Recombinant, FLAG-tag, Sequencing, Labeling, Protease Inhibitor, Reverse Transcription, Membrane, Transfection, Hybridization, Blocking Assay, Caspase-3 Activity Assay, Activity Assay, TUNEL Assay, Apoptosis Assay, Fluorescence, Luciferase, SYBR Green Assay, Expressing, Cloning, Extraction, Transformation Assay, Immunoprecipitation, Software
Related Articles
Immunohistochemical staining:Article Title: Paracrine effects of adipose-derived stem cells in cutaneous wound healing in streptozotocin-induced diabetic rats Article Snippet: A ccording to the International Diabetes Federation Diabetes Atlas of 2021, the number of adult patients with diabetes worldwide has reached 536.6 million.1 Diabetic foot ulcers (DFUs) are estimated to occur in 25% of all patients with diabetes, resulting in extensive emotional, functional and economic consequences for patients and an added burden on the healthcare system.2 The high glucose state caused by diabetes can impair wound healing, and the incidence rate of diabetic ulcers is >25%.3 The standard treatment of diabetic ulcers focuses on blood glucose control, offloading high pressure, surgical debridement of necrotic tissue, as well as antibiotic therapy for bacterial superinfection.4,5 However, in some cases, hard-to-heal diabetic ulcers are not responsive to these treatments and many patients with diabetic ulcers fail to adhere with these supportive and medical therapies.6 Fibroblasts, originating from mesenchymal cells, play a key role in maintaining extracellular matrix (ECM) homeostasis under normal conditions.7 It has been shown that the heterogeneity of fibroblasts plays an essential role in wound healing.8 The critical part of fibroblasts in wound healing has been known to differentiate into myofibroblasts, producing α-smooth muscle actin (α-SMA), accelerating wound healing.9 Mesenchymal stem cell therapies are an active area in diabetic wound healing, and abundant multipotent stem cells can be easily isolated from bone marrow and adipose tissue.10 Adipose tissue is one of the most abundant sources of mesenchymal stem cells.11 Adipose-derived stem cells (ASCs) are pluripotent mesenchymal stem cells derived from bone marrow, which have been found to promote wound healing.12 However, transplantation of stem cells can lead to tumour formation and tissue distortion.13 In recent years, researchers have paid much attention to taking advantage of the stem cell secretome to avoid the Paracrine effects of adipose-derived stem cells in cutaneous wound healing in streptozotocin-induced diabetic rats Staining:Article Title: Paracrine effects of adipose-derived stem cells in cutaneous wound healing in streptozotocin-induced diabetic rats Article Snippet: A ccording to the International Diabetes Federation Diabetes Atlas of 2021, the number of adult patients with diabetes worldwide has reached 536.6 million.1 Diabetic foot ulcers (DFUs) are estimated to occur in 25% of all patients with diabetes, resulting in extensive emotional, functional and economic consequences for patients and an added burden on the healthcare system.2 The high glucose state caused by diabetes can impair wound healing, and the incidence rate of diabetic ulcers is >25%.3 The standard treatment of diabetic ulcers focuses on blood glucose control, offloading high pressure, surgical debridement of necrotic tissue, as well as antibiotic therapy for bacterial superinfection.4,5 However, in some cases, hard-to-heal diabetic ulcers are not responsive to these treatments and many patients with diabetic ulcers fail to adhere with these supportive and medical therapies.6 Fibroblasts, originating from mesenchymal cells, play a key role in maintaining extracellular matrix (ECM) homeostasis under normal conditions.7 It has been shown that the heterogeneity of fibroblasts plays an essential role in wound healing.8 The critical part of fibroblasts in wound healing has been known to differentiate into myofibroblasts, producing α-smooth muscle actin (α-SMA), accelerating wound healing.9 Mesenchymal stem cell therapies are an active area in diabetic wound healing, and abundant multipotent stem cells can be easily isolated from bone marrow and adipose tissue.10 Adipose tissue is one of the most abundant sources of mesenchymal stem cells.11 Adipose-derived stem cells (ASCs) are pluripotent mesenchymal stem cells derived from bone marrow, which have been found to promote wound healing.12 However, transplantation of stem cells can lead to tumour formation and tissue distortion.13 In recent years, researchers have paid much attention to taking advantage of the stem cell secretome to avoid the Paracrine effects of adipose-derived stem cells in cutaneous wound healing in streptozotocin-induced diabetic rats other:Article Title: A double-agent microRNA regulates viral cross-kingdom infection in animals and plants Article Snippet: 4% Paraformaldehyde Fix Solution (PFA) , Article Title: In Vivo Fate of CXCR2-Overexpressing Mesenchymal Stromal/Stem Cells in Pulmonary Diseases Monitored by Near-Infrared Region 2 Imaging. Article Snippet: Lung-associated diseases pose a huge threat to human society.. Mesenchymal stromal/stem cells (MSCs) hold great promise in the treatment of pulmonary diseases through cell transdifferentiation, paracrine factors, immune regulation, EV secretion, and drug loading.. However, intravenous injection of MSCs often resulted in limited lesion tropism and apparent off-target accumulation. |